Digital Health Advisor
Melinda Decker is a global biopharmaceutical and digital health leader with a mix of commercial and R&D expertise. She is currently a digital health consultant and also serves as an advisor to MIT’s Health Science & Technology program, to Mymee, a JLabs Digital Therapeutics company working in autoimmune disease and to HealthMode, focused on AI-enabled clinical trials and validating new digital biomarkers. Previously, Melinda was the Oncology & Diabetes TA Head for AstraZeneca’s Digital Health team. She holds an MS in Biochemical Engineering and an MBA in Finance and Marketing.